Fri, Jun. 17, 9:18 AM| Fri, Jun. 17, 9:18 AM | 3 Comments
Thu, Apr. 14, 4:10 PM
- Ceres (NASDAQ:CERE): FQ2 EPS of -$0.09
- Revenue of $0.35M (+2.9% Y/Y)
Thu, Jan. 14, 4:09 PM
- Ceres (NASDAQ:CERE): Q1 EPS of -$0.39
- Revenue of $0.9M (+125.0% Y/Y)
Nov. 24, 2015, 12:40 PM
Nov. 23, 2015, 4:12 PM
- Ceres (NASDAQ:CERE): FQ1 EPS of -$4.57 vs. -$6.48 in FY14
- Revenue of $2.72M (+13.3% Y/Y)
Sep. 30, 2015, 12:43 PM
Sep. 29, 2015, 12:41 PM
Sep. 3, 2015, 9:12 AM
Aug. 21, 2015, 9:30 AM
- Agricultural biotech Ceres (NASDAQ:CERE) drops 9% premarket on modest volume in response to its announcement that it has entered into a securities purchase agreement with certain institutional investors for the sale of 1,598,478 shares of common stock at $1.22 per share and warrants to purchase up to 1,198,859 shares of stock at $1.22 at a price of $0.09375 per warrant. The warrants are exercisable in six months.
- Yesterday's close was $1.24.
Aug. 19, 2015, 12:45 PM
Aug. 17, 2015, 9:15 AM
Aug. 12, 2015, 12:44 PM
- Thinly traded nano cap Ceres (CERE +172.9%) zooms north on a 10x surge in volume in response to its announcement that the USPTO issued a patent covering its iCODE multi-gene trait development system. According to the company, the patent is a key milestone in its plan to further develop and license the technology to other crop companies.
- The iCODE system is designed to rapidly create, evaluate and select optimal combinations of genes and their control components for next-generation biotechnology traits in crops like corn and soybean. It utilizes the plant cell's own gene-shuffling system to create thousands of test plants with various combinations of pre-selected genes and promoters (on/off switches for genes).
Jul. 27, 2015, 12:48 PM
Jul. 10, 2015, 4:15 PM
- Ceres (NASDAQ:CERE): FQ3 EPS of -$0.98 vs. -$1.35 in 3Q14
- Revenue of $1.12M (+40% Y/Y)
Jun. 19, 2015, 11:47 AM
- Ceres (CERE -2.7%) says it will restructure its Brazilian seed operations and is exploring discussions with additional local partners to support the continued development and commercialization of its technology in Brazil.
- CERE says the realignment is intended to focus on food and forage opportunities and biotechnology traits for sugarcane and other crops.
- Once fully implemented, CERE expects its plan to deliver cash savings of up to $6M-$8M in FY 2016.
Jun. 9, 2015, 12:47 PM